December 24, 2025 a 07:43 am
CAH: Fundamental Ratio Analysis - Cardinal Health, Inc.
Cardinal Health, Inc. is a notable player in the healthcare services sector, offering an integrated suite of solutions and products worldwide. The company's strong foothold in pharmaceutical and medical segments positions it well for diverse market conditions. Investors should consider its solid market presence and strategic operations across the globe.
Fundamental Rating
Cardinal Health, Inc. presents a mixed fundamental outlook with a rating of C+ indicating moderate performance across several essential financial metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 1 | |
| Return On Assets | 4 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 1 |
Historical Rating
The historical performance of Cardinal Health shows recent improvements in the fundamental scores, highlighting efforts towards better financial management and resource allocation.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | 2 | 4 | 1 | 4 | 1 | 2 | 1 |
| -- Previous -- | 0 | 4 | 1 | 4 | 1 | 2 | 1 |
Analyst Price Targets
Analyst targets indicate a relatively optimistic outlook with a high forecast of $243 and a consensus median at $220, reflecting potential growth expectations in the market.
| High | Low | Median | Consensus |
|---|---|---|---|
| $243 | $186 | $220 | $215 |
Analyst Sentiment
The majority analyst sentiment suggests a 'Buy' rating, indicating confidence in the stock's potential growth trajectory.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 16 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Cardinal Health, Inc. presents a moderate investment opportunity with a 'C+' rating, largely driven by strong DCF and ROA metrics. The company exhibits robust market positioning but faces challenges in debt management and equity returns. Analyst sentiment leans toward 'Buy', suggesting potential upside in stock value. Investors should weigh the positive long-term growth outlook against existing financial constraints. Strategic focus on enhancing fundamental performance could strengthen its investment appeal.